Evercore Inc.

What they do

Evercore provides strategic advisory services on mergers, acquisitions, divestitures, leveraged buyouts, joint ventures, defense and shareholder advisory, and restructuring. The Investment Banking & Equities segment also includes underwriting, private capital advisory and fundraising, equities research and sales and trading. The smaller Investment Management segment covers Wealth Management and interests in private equity funds the firm does not manage.

Revenue drivers

• Investment Banking & Equities — Advisory Fees — Advisory fees are the largest revenue source, tied to M&A, restructuring, liability management and capital advisory engagements; the segment generated $3.69 billion, or 98% of revenues excluding Other Revenue, net, in 2025.
• Investment Banking & Equities — Underwriting and Placement — Fees from underwriting and private placement activities, including bookrunning roles; Q2 2026 underwriting fees were $97.1 million versus $32.2 million in Q2 2025.
• Commissions and Related Revenue (Equities) — Commissions, research subscription fees and riskless principal trading revenues; revenue trends correlate with market volumes and volatility.
• Investment Management — Management fees based on assets under management, fiduciary fees and gains or losses on principal investments, including equity interests in investment partnerships.

Recent performance

Second quarter 2026 net revenues were $990.2 million on a U.S. GAAP basis, up 19% from $833.8 million in Q2 2025, and first half 2026 net revenues were $2.38 billion, up 56% from $1.53 billion. Q2 2026 U.S. GAAP operating income was $146.6 million with a 14.8% margin, while adjusted operating income was $189.7 million at a 19.0% margin. Q2 2026 U.S. GAAP diluted EPS was $2.32 versus $2.36 in Q2 2025; adjusted diluted EPS was $2.91 versus $2.42. First half 2026 U.S. GAAP operating income was $477.3 million at a 20.0% margin, up 293 basis points from the prior year period. The firm reported record second quarter and first half revenues, with record Q2 revenues in North America Strategic Advisory, Private Funds Group and Equities, and best-ever quarters in Underwriting and Wealth Management.

Strategy

Evercore positions itself as an independent advisory firm free of the conflicts created by commercial banking or significant proprietary trading. The firm is adding senior talent: as of June 30, 2026 the Investment Banking franchise had 188 Senior Managing Directors, with four SMDs joining since the last earnings call and seven more committed, in areas including Restructuring in the U.S. and Europe, Healthcare, Chemicals, Equity Capital Markets and Frankfurt. It returned $822.9 million to shareholders in the first six months of 2026 through dividends and repurchases of 2.3 million shares at an average price of $324.60, and declared a quarterly dividend of $0.89 per share. The Private Funds Group ranked #1 in Private Equity International's 2025 Placement Agent Ranking.

Risks

• M&A cycle dependence — Most revenues come from advisory fees realized only on completed transactions, which can fail due to financing, regulatory, shareholder or market issues outside Evercore's control.
• Market and economic conditions — Unfavorable markets, rising rates, tariff threats or geopolitical events can reduce the volume and value of transactions involving the Investment Banking & Equities business.
• No capital commitment ability — Evercore does not provide financing or commit capital, so clients' reliance on credit and capital markets can affect the size, timing and completion of transactions.
• Equities volume sensitivity — Equities revenue is correlated with market volumes, which generally decrease in periods of low volatility or unfavorable market conditions.

Outlook

Management highlighted record second quarter and first half 2026 revenues, with growth across North America Strategic Advisory, Private Funds Group, Equities, Underwriting and Wealth Management. The firm continues to add Investment Banking Senior Managing Directors, including committed hires in Restructuring, Healthcare, Chemicals, Equity Capital Markets and Frankfurt, and maintained its quarterly dividend at $0.89 per share. No specific forward financial guidance was provided in the excerpted materials.